Company Comparison
FibroGen vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | FibroGen | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | San Francisco, CA | San Diego |
| Founded | 1993 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Series A |
| Total Funding | — | $48M |
| Valuation | — | — |
What They Build
FibroGen
Biopharmaceutical company focused on developing therapies for fibrotic diseases, anemia, and cancer through innovative drug discovery.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
FibroGen
AI Therapeutics
No investors listed.
Sector Overlap
Both FibroGen and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.